Personnel Information

写真a

WATANABE Mamoru


Job title

Executive Director

Graduating School 【 display / non-display

  • Keio University, Faculty of Medicine, 1979, Graduated

Graduate School 【 display / non-display

  • Keio University, Graduate School, Division of Medicine, Doctor's Course, 1984, Completed

Degree 【 display / non-display

  • Medical doctor, Keio University

Campus Career 【 display / non-display

  • 2000.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Gastroenterology and Hepatology, Professor
  • 2017.04
    -
    2017.09
    Tokyo Medical and Dental University, Board Member, Executive Director
  • 2017.10
    -
    Now
    Tokyo Medical and Dental University, Board Member, Executive Director

Academic Society Affiliations 【 display / non-display

  • The Japanese Society for Gastroenterology

  • The Japanese Society of Internal Medicine

  • The Japanese Society for Mucosal Immunology

  • The Japan Gastroenterological Endoscopy Society

  • American Gastroenterological Association

Academic Activity 【 display / non-display

  • The Japanese Society for Gastroenterology Councilor
  • The Japanese Society for Mucosal Immunology Councilor
  • American Gastroenterological Association Fellow

Research Areas 【 display / non-display

  • Gastroenterology

 

Published Papers & Misc 【 display / non-display

  • Wan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mao Okada, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi. Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice. Cancers (Basel). 2019.10; 11 (10): ( PubMed, DOI )

  • Tadakazu Hisamatsu, Shingo Kato, Reiko Kunisaki, Minoru Matsuura, Masakazu Nagahori, Satoshi Motoya, Motohiro Esaki, Norimasa Fukata, Satoko Inoue, Takeshi Sugaya, Hirotake Sakuraba, Fumihito Hirai, Kenji Watanabe, Takanori Kanai, Makoto Naganuma, Hiroshi Nakase, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi, Masanori Nojima, Takayuki Matsumoto, . Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). J. Gastroenterol.. 2019.10; 54 (10): 860-870. ( PubMed, DOI )

  • Sayaka Tsuda, Azusa Sameshima, Michikazu Sekine, Haruna Kawaguchi, Daisuke Fujita, Shintaro Makino, Akio Morinobu, Yohko Murakawa, Kiyoshi Matsui, Takao Sugiyama, Mamoru Watanabe, Yasuo Suzuki, Masakazu Nagahori, Atsuko Murashima, Tatsuya Atsumi, Kenji Oku, Nobuaki Mitsuda, Syuji Takei, Takako Miyamae, Naoto Takahashi, Ken Nakajima, Shigeru Saito, . Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study. Mod Rheumatol. 2019.09; 1-10. ( PubMed, DOI )

  • Hajime Yamazaki, Katsuyoshi Matsuoka, Jovelle Fernandez, Toshifumi Hibi, Mamoru Watanabe, Tadakazu Hisamatsu, Shunichi Fukuhara. Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network). BMJ Open. 2019.09; 9 (9): e030134. ( PubMed, DOI )

  • Tomoo Nakagawa, Taku Kobayashi, Kiyohiro Nishikawa, Fumika Yamada, Satoshi Asai, Yukinori Sameshima, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi. Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice. Intest Res. 2019.08; ( PubMed, DOI )

display all >>

Books etc 【 display / non-display

  • Mamoru Watanabe. Endoscopy in Inflammatory Bowel Disease: Asian Perspectives with Respect toJapan. Springer, 2018.11 Part Ⅳ Endoscopy in IBD: International Difference

  • Masakazu Nagahori. Diagnosis of Ulcerative Colitis:Typical Findings and Diagnostic Criteria. Springer, 2018.11 Part Ⅱ Endoscopic Diagnosis of IBD

  • Nagaishi T, Watanabe M. Crohn's Disease and Ulcerative Colitis: from Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach.. 2017.03 Paradigm of T cell differentiation in IBD: Crohn's disease and ulcerative colitis (ISBN : 978-3-319-33701-2)

Conference Activities & Talks 【 display / non-display

  • Kento Takenaka, Kazuo Ohtsuka, Mamoru Watanabe. Small bowel endoscopic healing of Crohn’s disease treated with anti-TNF antibodies. JDDW2019 2019.11.21

  • Shuji Hibiya, Kiichiro Tsuchiya, Ryu Nishimura, Sho Watanabe, Nobuhiro Katsukura, Tomoaki Shirasaki, Ryuichi Okamoto, Mamoru Watanabe. Establishment of chronic inflammation model using human small intestinal and colonic organoids. UEG Week 2019 2019.10.23 Fira Gran Via, Barcelona, Spain

  • Yoshihito Kano, Teklab Gebregiworgis, Christopher Marshall,Mitsuhiko Ikura, Michael Ohh. Inhibition of SHP2 promotes the tyrosyl phosphorylation of KRAS and suppresses the pancreatic cancer growth. 第78回日本癌学会学術集会 2019.09.28 京都

  • Mina Nakagawa, Kanako Noritake, Kumiko Yamaguchi, Janelle Moross, Jun Tsuruta, Keiichi Akita. Introduction of Clinical Exchange Training for Medical and Dental Students. AMEE 2019 2019.08.26 Austria Centre Vienna

  • Daiki Yamada, Takashi Nagaishi, Taro Watabe, Naoya Tsugawa, Yudai Kojima, Takahiro Adachi, Mamoru Watanabe. Analysis of Ileocecal Immune Response in an Animal Model of Colitis. ICMI 2019 2019.07.17 Brisbane Convention & Exhibition Centre(Brisbane)

display all >>